Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Technology Process of (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol

(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol

Base Information
  • Chemical Name:(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
  • CAS No.:859853-30-8
  • Deprecated CAS:947688-34-8
  • Molecular Formula:C19H24N6O2
  • Molecular Weight:368.43
  • Hs Code.:
  • UNII:VKU5X213Q7
  • ChEMBL ID:CHEMBL3545396
  • DSSTox Substance ID:DTXSID3042689
  • Metabolomics Workbench ID:152783
  • NCI Thesaurus Code:C68832
  • Pharos Ligand ID:2V6P732V1HB3
  • Wikidata:Q27075363
  • Mol file:859853-30-8.mol
(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol

Synonyms:(14C)BMS-690514;(3R,4R)-4-amino-1-((4-((3-methoxyphenyl)amino)pyrrolo(2,1-f)(1,2,4)triazin-5-yl)methyl)-3-piperidinol;BMS-690514

Suppliers and Price of (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Matrix Scientific
  • (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo-[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol >95%
  • 100mg
  • $ 1853.00
  • Matrix Scientific
  • (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo-[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol >95%
  • 250mg
  • $ 3927.00
  • Matrix Scientific
  • (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo-[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol >95%
  • 500mg
  • $ 6519.00
  • J&W Pharmlab
  • (3R,4R)-4-Amino-1-[4-(3-methoxy-phenylamino)-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl]-piperidin-3-ol 96%
  • 500mg
  • $ 6287.00
  • J&W Pharmlab
  • (3R,4R)-4-Amino-1-[4-(3-methoxy-phenylamino)-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl]-piperidin-3-ol 96%
  • 5g
  • $ 39611.00
  • J&W Pharmlab
  • (3R,4R)-4-Amino-1-[4-(3-methoxy-phenylamino)-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl]-piperidin-3-ol 96%
  • 1g
  • $ 11317.00
  • J&W Pharmlab
  • (3R,4R)-4-Amino-1-[4-(3-methoxy-phenylamino)-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl]-piperidin-3-ol 96%
  • 10mg
  • $ 298.00
  • J&W Pharmlab
  • (3R,4R)-4-Amino-1-[4-(3-methoxy-phenylamino)-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl]-piperidin-3-ol 96%
  • 100mg
  • $ 1796.00
  • J&W Pharmlab
  • (3R,4R)-4-Amino-1-[4-(3-methoxy-phenylamino)-pyrrolo[2,1-f][1,2,4]triazin-5-ylmethyl]-piperidin-3-ol 96%
  • 50mg
  • $ 998.00
  • DC Chemicals
  • BMS-690514 >98%
  • 50 mg
  • $ 792.00
Total 28 raw suppliers
Chemical Property of (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
Chemical Property:
  • PKA:14.41±0.40(Predicted) 
  • PSA：100.94000 
  • Density:1.41 
  • LogP:2.08660 
  • Solubility.:Soluble in DMSO 
  • XLogP3:0.7
  • Hydrogen Bond Donor Count:3
  • Hydrogen Bond Acceptor Count:7
  • Rotatable Bond Count:5
  • Exact Mass:368.19607403
  • Heavy Atom Count:27
  • Complexity:483
Purity/Quality:

99.9% *data from raw suppliers

(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo-[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol >95% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CCC(C(C4)O)N
  • Isomeric SMILES:COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CC[C@H]([C@@H](C4)O)N
  • Recent ClinicalTrials:A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin
  • Recent EU Clinical Trials:An Open-Label Randomized, Parallel, Two-Arm Phase II Study Comparing BMS-690514 + Letrozole with Lapatinib + Letrozole in Recurrent or Metastatic Breast Cancer Patients Who Are Hormone Receptor Positive Despite HER2 Status And Who Relapsed While Receiving or After Completing Adjuvant Antiendocrine Therapy
  • Recent NIPH Clinical Trials:Clinical Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 859853-30-8

Total 8 Pictures about this product